2019-01-26

Re: [#DIV28SUPER] 2019 Division 28 Award Winners!

Very well deserved, congratulations Drs. Budney, Kurti, and Borodovsky!

Best,

Krista Lisdahl

On Sat, Jan 26, 2019 at 8:28 AM Catherine Stanger <Catherine.Stanger@dartmouth.edu> wrote:

Hello Division 28!

 

Please join me in congratulating our 2019 Division 28 Award Winners!  We had excellent candidates nominated in all three categories, and I would like to thank all the nominees and those who nominated them for their participation this year.  Division 28 has an outstanding roster of early career and senior scientists doing excellent work.

 

Now, for our winners.

 

MED Associates Brady-Schuster Award honors a mid-career or senior scientist (at least 15 years after doctoral degree) who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance abuse.

This year's winner is Alan Budney, Ph.D. Dr. Budney is Professor in the Department of Psychiatry and the Center for Technology and Behavioral Health at the Geisel School of Medicine at Dartmouth. 

 

Young Psychopharmacologist Award honors a young scientist conducting original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology.

This year's winner is Allison Kurti, Ph.D.  Dr. Kurti is Assistant Professor in the Departments of Psychiatry and Psychological Science and the Vermont Center on Behavior and Health at the University of Vermont.

 

Outstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance abuse. 

This year's winner is Jake Borodovsky, Ph.D.  Dr. Borodovsky completed his Ph.D. in Health Policy and Clinical Practice (Epidemiology and statistics concentration) at The Dartmouth Institute & The Center for Technology and Behavioral Health of the Geisel School of Medicine at Dartmouth. He is currently a Postdoctoral Researcher at the Health and Behavior Research Center of the Washington University School of Medicine.

 

Congratulations to all, and we look forward to your presentations in Chicago!

 

Regards,

Cathy Stanger

Division 28 Awards Chair

 

Catherine Stanger, Ph.D.

Associate Professor

Center for Technology and Behavioral Health

Geisel School of Medicine at Dartmouth

Dartmouth College

46 Centerra Parkway

EverGreen Center Suite 300

HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

www.c4tbh.org

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28



--
Krista M. Lisdahl, Ph.D.
(formerly Krista Lisdahl Medina)
Associate Professor
Director, Brain Imaging and Neuropsychology (BraIN) Lab
Chair, Women in Neuropsychology APA SCN Subcommittee
Adolescent Brain Cognitive Development (ABCD) UWM Site PI
University of Wisconsin-Milwaukee
Psychology Department, Garland Hall Rm 224
2441 East Hartford Ave
Milwaukee, WI 53211 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] 2019 Division 28 Award Winners!

Hello Division 28!

 

Please join me in congratulating our 2019 Division 28 Award Winners!  We had excellent candidates nominated in all three categories, and I would like to thank all the nominees and those who nominated them for their participation this year.  Division 28 has an outstanding roster of early career and senior scientists doing excellent work.

 

Now, for our winners.

 

MED Associates Brady-Schuster Award honors a mid-career or senior scientist (at least 15 years after doctoral degree) who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance abuse.

This year’s winner is Alan Budney, Ph.D. Dr. Budney is Professor in the Department of Psychiatry and the Center for Technology and Behavioral Health at the Geisel School of Medicine at Dartmouth. 

 

Young Psychopharmacologist Award honors a young scientist conducting original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology.

This year’s winner is Allison Kurti, Ph.D.  Dr. Kurti is Assistant Professor in the Departments of Psychiatry and Psychological Science and the Vermont Center on Behavior and Health at the University of Vermont.

 

Outstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance abuse. 

This year’s winner is Jake Borodovsky, Ph.D.  Dr. Borodovsky completed his Ph.D. in Health Policy and Clinical Practice (Epidemiology and statistics concentration) at The Dartmouth Institute & The Center for Technology and Behavioral Health of the Geisel School of Medicine at Dartmouth. He is currently a Postdoctoral Researcher at the Health and Behavior Research Center of the Washington University School of Medicine.

 

Congratulations to all, and we look forward to your presentations in Chicago!

 

Regards,

Cathy Stanger

Division 28 Awards Chair

 

Catherine Stanger, Ph.D.

Associate Professor

Center for Technology and Behavioral Health

Geisel School of Medicine at Dartmouth

Dartmouth College

46 Centerra Parkway

EverGreen Center Suite 300

HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

www.c4tbh.org

2019-01-11

[#DIV28SUPER] Undergradaute Scholarship to APA travel

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] Revised: Open Call for Papers: Mental Health Professionals with Lived Experience of Mental Illness




Sent from my iPhone
On Jan 11, 2019, at 11:46 AM, Sokol-Chang, Rose <RSokol-Chang@apa.org> wrote:

Hi Ronald,

 

I sent you the call below in a non-final manner last month for posting on the Div 28 listserv. I've replaced with the final version below – would you mind posting it on the Div 28 listserv again?

 

Thanks!

 

Rose

 

 

Open Call for Papers: Mental Health Professionals with Lived Experience of Mental Illness Psychological Services

Special Package Editors: Dr. Jennifer Boyd, Guest Editor; Dr. Femina Varghese, Associate Editor

Submission Deadline: May 1, 2019

 

This call is developed in memory of Dr. Fred Frese

 

The editorial staff at the journal for American Psychological Association Division 18 (Psychologists in Public Service), Psychological Services, is inviting manuscripts for a special section on licensed mental health professionals who have a lived experience of mental illness. Sometimes referred to as "prosumers", this group of providers is uniquely positioned to fight stigma and promote the mental health recovery model by serving as examples and by providing a consumer perspective throughout our field. Similarly, professionals who have immediate family members with mental illness can also provide an important personal perspective. Overall, personal experience with psychiatric disability is an important but often invisible identity factor. This is an aspect of diversity and inclusion that is particularly relevant in the mental health workplace.

 

The current published literature about mental health workers with lived experience is mostly limited to scattered first-person accounts. Empirical work is mainly focused on peer specialists, who are expected to disclose, and thus different from licensed professionals who can choose whether or not to disclose.

 

Qualitative, quantitative, and mixed-methods studies, as well as systematic reviews, empirically-informed consensus statements, theoretical papers, meta-analyses, and first-person accounts are all welcomed. First-person accounts should be limited to 3-5 double-spaced manuscript pages including any references.

 

The field would be enriched by papers on topics including, but not limited to:

 

· Prevalence of prosumers in the public service mental health workplace (e.g., related measurement issues; progress on federal or other official targets for percentages of staff with psychiatric disabilities at all pay grades and/or career stages)

· Best practices for training, recruiting, hiring, managing, and/or retaining prosumers in the mental health workplace (e.g., features of a welcoming organizational climate; culture change; effective accommodations; personal therapy requirements for trainees)

· Partnering with peer specialists to achieve desired outcomes

· Appropriate boundaries under the recovery model (e.g., the effect of disclosure to patients on therapeutic alliance and clinical outcomes)

· Stigma and discrimination targeting this group, including causal factors (e.g., the clinician's illusion; culture of nondisclosure) and stigma-reduction strategies

· Impaired professionals, burnout, secondary trauma, and how to regain wellness and productivity

· Parallels with and lessons learned from other invisible identities such as LGBTQQIA (lesbian, gay, bisexual, transgender, queer, questioning, intersex, or asexual); intersectionality; resilience

· First-person accounts, narratives, or statements from individual or multiple prosumers, in the context of authors' professional activities in psychology (these should be 3-5 double-spaced manuscript pages including references), from any developmental stage (student, early career, mid-career, late career, and retirement)

· Mental health professionals who have immediate family members with mental illness, or who treat patients who have the same condition that the professionals themselves or their family members have experienced.

 

APA Division 18 (Psychologists in Public Service) welcomes manuscripts related to these areas including, but not limited to, work being conducted in the following domains:

 

· Police and public safety settings

· Criminal justice settings including courts, prisons, and prison reentry programs

· Educational systems at all levels

· Hospitals and community clinics

· Indian Health Service

· Department of Veterans Affairs

 

The deadline for receipt of papers for this special section is May 1, 2019. Please follow the Instructions to Authors information located on the Psychological Services website at: http://www.apa.org/pubs/journals/ser. Manuscripts must be submitted electronically through the Manuscript Submission Web Portal at https://www.editorialmanager.com/svs/default.aspx.

 

Please specify in your cover letter that the submission is intended for the special section on Mental Health Professionals with Lived Experience of Mental Illness, and address your submission cover letter to Drs. Jennifer Boyd and Femina Varghese. All papers submitted will be initially screened by the editorial board. If evaluated as appropriate for the journal, papers will then be sent out for blind peer review. For further questions related to this special section, please contact Dr. Boyd at jennifer.boyd@va.gov and Dr. Varghese fvarghese@uca.edu.

 

 

 

Rose Sokol-Chang, PhD
Publisher, APA Journals
American Psychological Association

 

750 First Street NE, Washington DC 20002-4242
t. (202) 336-5667

 

 

 

 

 

 

2019-01-09

[#DIV28SUPER] Job Post Psychologist – University of Kansas

Posted on the behalf of Richard Yi.

The Cofrin Logan Center for Addiction Research and Treatment, in collaboration with the Counseling and Psychological Services (CAPS) at the University of Kansas, is seeking a Psychologist with Addictions specialty.

General Responsibilities: The Psychologist will provide counseling, psychotherapy and psychological testing to eligible students of the University in the domain of substance use disorder and related disorders. The Psychologist will also provide outreach and consultation to students, faculty and staff, and supervise to graduate students and other students-in-training. This percent of time worked for this position will be 50%-100% and is negotiable based on the needs of the department and the successful candidate. Salary will be commensurate with experience.
Required Qualifications
1. Doctorate (Ph.D.) in Clinical Psychology or Counseling Psychology from an APA accredited program and one year of related professional experience.
2. Successful completion of APA accredited doctoral internship in Psychology.
3. Strong written communication skills as evidenced by application materials.
4. Licensed or immediately license eligible by start date for permanent license at the doctoral level in the state of Kansas.
5. Experience in the evidence-based treatment of substance use and related disorders.
Preferred Qualifications
1. Experience in supervision and training.
2. Experience in group therapy.
3. Experience in brief/solution focused therapy techniques.
4. Experience in DSM-V diagnosis and assessment of mental status.
5. Experience in outreach and prevention.
6. Demonstrated experience in and commitment to promoting and enhancing diversity and commitment to ongoing development of multicultural competence.
7. Strong verbal communication skills.
8. Demonstrated ability in and significant experience with working collaboratively with a diverse population of students, faculty, staff, administrators, and other members of the community.
9. Ability to work cooperatively and collaboratively on interdisciplinary team, to take initiative, and to be flexible in response to developing demands and challenges of the position.
10. Experience in clinical role as part of a research team.
11. Certified in alcohol and/or drug abuse treatment or licensed for clinical addictions treatment
Review of application will begin on January 21, 2019 and continues as needed to ensure a large, high quality, and diverse applicant pool.
For more information and to apply: https://sjobs.brassring.com/TGnewUI/Search/home/HomeWithPreLoad?PageType=JobDetails&partnerid=25752&siteid=5541&AReq=13479BR#jobDetails=3711370_5541
Direct questions and inquiries to Richard Yi: ryi1@ku.edu


Richard Yi, Ph.D.
Director, Cofrin Logan Center for Addiction Research and Treatment
Professor, Department of Psychology
University of Kansas, Lawrence, KS 66045
Email: ryi1@ku.edu Phone: 785-864-6476
https://addiction.ku.edu

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

Re: [#DIV28SUPER] REMINDER: Call for Nominations - Division 28 Awards - DEADLINE APPROACHING!!

Hey Cath,


In the way of an FYI, I'm planning to nominate Allison Kurti for the Young Psychopharmacologist Award.  I think she's a strong candidate.  


Steve


Stephen T. Higgins, Ph.D.
Director, Vermont Center on Behavior and Health
Virginia H. Donaldson Professor of Translational Science
Departments of Psychiatry and Psychological Science
Vice Chair, Department of Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT  05401-1419

VCBH Administrator: Marissa Palmer, MPH
marissa.palmer@uvm.edu
802-656-0079



From: div28super reaches div28 and div28m and its nested lists (e.g. div28s) <DIV28SUPER@LISTS.APA.ORG> on behalf of Catherine Stanger <Catherine.Stanger@DARTMOUTH.EDU>
Sent: Thursday, January 3, 2019 2:22 PM
To: DIV28SUPER@LISTS.APA.ORG
Subject: [#DIV28SUPER] REMINDER: Call for Nominations - Division 28 Awards - DEADLINE APPROACHING!!
 

Dear Division 28 Colleagues,

Happy new year to all! 

 

I'm reaching out to remind you that the deadline for award submissions is in less than 2 weeks and to encourage you to submit nomination materials for APA Division 28 Awards for the 2019 APA meeting in Chicago.  

 

Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year's nominees.  The deadline for materials is January 15, 2019.  

 

Regards,

 

Cathy Stanger

 

 

Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2019-01-07

[#DIV28SUPER] NIH HEAL (Helping to End Addiction Long-term) Initiative: Funding Opportunity Announcements

Dear Investigator,

 

To address the opioid crisis, NIH has developed the NIH HEAL (Helping to End Addiction Long-term) Initiative.  The following funding opportunity announcement.

Table of contents:

I.   TA Webinar for NIDA HEAL Prevention Funding Opportunities: January 17, 2019 12:30 - 2:00 p.m. - Please register and save the date

II.  HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)   (RFA-HL-19-028)

III.HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) (RFA-HL-19-029)

IV.                  For Information about other HEAL (Helping to End Addiction Long-termS Initiative) please click here.
-----------------

I.TA Webinar for NIDA HEAL Prevention Funding Opportunities: January 17, 2019 12:30 - 2:00 p.m. - Please register and save the date

A technical assistance webinar is scheduled to assist potential applicants to the following prevention specific HEAL initiatives:

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) (UG3/UH3 Clinical Trial Required (RFA-DA-19-035)

And

HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) Initiative (U24 Clinical Trial Not Allowed) RFA-DA-19-034

The intent of this pre-application webinar is to provide an overview of the HEAL Prevention FOAs and to address general questions from potential applicants.

 

Attendees are encouraged to register for the webinar in advance. The webinar is optional and not required for application submission. The webinar may conclude before the scheduled time depending on the number of questions.

 

Following the webinar, NIDA will post the slides that are presented. Prospective applicants with inquiries concerning the FOAs who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar. 

 

Webinar Information
Date: January 17, 2019
Time: 12:30 - 2:00 pm EST

Event address for attendees (to register and attendhttps://nih.webex.com/nih/onstage/g.php?MTID=e377439f43efc0136f1c75ecb8938b880):

 

FOAs to be discussed

Please click on the links below to see the full announcements and instructions.

 

HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) Initiative (U24 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-034.html

 

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) (UG3/UH3 Clinical Trial Required)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-035.html

Please share this information within your networks and widely.

 

For more information contact:

Jacqueline Lloyd, PhD, MSW

Deputy Branch Chief

Prevention Research Branch

Division of Epidemiology, Services and Prevention Research

National Institute on Drug Abuse

National Institutes of Health

US Department of Health and Human Services

6001 Executive Blvd. Room 5173

Bethesda, MD 20892-9589

Email: lloydj2@nida.nih.gov

Phone: 301-443-8892

Fax: 301-443-2636

 

II.  HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)   (RFA-HL-19-028)

Application due date:  February 27, 2019

This FOA invites applications that propose to elucidate basic sleep and circadian mechanisms closely-coupled to the risk of opiate use disorder (OUD), the pathobiology of opiate withdrawal, and that influence the response to medication-assisted treatment (MAT).  Studies are needed to apply advances in understanding sleep and circadian biology to improving our understanding of OUD, the directionality of sleep and OUD interactions, and the opportunities to improve therapy and outcome.  Multi-disciplinary, multiple-investigator teams combining expertise in sleep and circadian neurobiology with the neurobiology OUD and pharmacology of MAT are strongly encouraged.  This FOA is only open to the study of OUD relevant mechanisms and pathobiology. The study of other drugs of abuse will not be responsive.

See RFA-HL-19-028 for complete details.

Correspondence should be directed to”

Aaron D. Laposky, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7837
Email: laposkya@nhlbi.nih.gov

Steve Grant, PhD
National Institute on Drug Abuse (NIDA)
Telephone: (301) 443-8869
Email:
sgrant@nida.nih.gov

III. HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) (RFA-HL-19-029)

Application due date: February 27, 2019

his FOA invites applications for human subjects research to elucidate sleep/circadian mechanisms closely-coupled to the risk of opiate use disorder (OUD), the pathobiology of opiate withdrawal, and the response to medication-assisted treatment (MAT). Identifying sleep/circadian mechanisms and determining the directionality of sleep and OUD interactions addresses a knowledge gap and new opportunities for improved therapy and outcome.  Multi-disciplinary, multiple-investigator teams of researchers combining expertise in clinical research and mechanisms of sleep/circadian science and OUD/MAT are strongly encouraged. Clinical trials focused on mechanistic endpoints and/or understanding how an intervention works may be proposed. This FOA is only open to the study of OUD relevant mechanisms and pathobiology. The study of other drugs of abuse or efficacy focused trials will not be responsive.

See RFA-HL-19-029 for complete details.

Correspondence should be directed to:

Aaron D. Laposky, PhD 
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: (301) 827-7837
Email: 
laposkya@mail.nih.gov

Steve Grant, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8869
Email:sgrant@nida.nih.gov

 

IV . For Information about other HEAL (Helping to End Addiction Long-termS Initiative) please click here.

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

 

2019-01-03

[#DIV28SUPER] unsubscribe




Linda Carter Sobell, Ph.D., ABPP
President's Distinguished Professor of Excellence
Board Certified in Behavioral and Cognitive Psychology
Licensed Psychologist
Associate Director of Clinical Training
Co-Director, Healthy Lifestyles Guided Self-Change Program
Motivational Interviewing Trainer
College of Psychology
Nova Southeastern University
3301 College Avenue
Ft. Lauderdale, FL 33314 USA
Cell Phone: 954-294-2366
Fax: 954-262-3895
e-mail: sobelll@nova.edu

Healthy Lifestyles Guided Self-Change Program web page: http://www.nova.edu/gsc

Free APP for iPhones and iPads and Android and Smartphones
iSelfChange™®, app is available 24/7, is confidential, innovative, free, and provides a non-stigmatizing way of helping people change their drinking (and smoking if smokers) without entering treatment. The app can be downloaded for free at the iTunes and Google Play stores by searching for iSelfChange™ or clicking on the following links.
iPhones: https://itunes.apple.com/us/app/iselfchange/id761033899?ls=1&mt=8
Android: https://play.google.com/store/apps/details?id=edu.nova.iSelfChange

Timeline and Other Forms:
All forms, instructions, and calendars related to using The Timeline Followback including the excel computerized programs for alcohol, drugs, and cigarettes (for MAC and PC) including foreign translations and as well as forms and instructions and motivational materials both in English and Spanish for the Family Tree Questionnaire, Drug History Questionnaire, and Brief Situational Confidence Questionnaire are available as free down loads. For all online forms go to http://www.nova.edu/gsc/forms/timeline-followback-forms.html

Aids for Changing Your Drinking On Your Own can be downloaded for free at
http://www.nova.edu/gsc/forms/change_alcohol_use.pdf



<https://www.facebook.com/guidedselfchangeclinic/timeline> <https://www.instagram.com/guidedselfchange>





_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] REMINDER: Call for Nominations - Division 28 Awards - DEADLINE APPROACHING!!

Dear Division 28 Colleagues,

Happy new year to all! 

 

I’m reaching out to remind you that the deadline for award submissions is in less than 2 weeks and to encourage you to submit nomination materials for APA Division 28 Awards for the 2019 APA meeting in Chicago.  

 

Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year’s nominees.  The deadline for materials is January 15, 2019.  

 

Regards,

 

Cathy Stanger

 

 

Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28